For instance, the adhesive ephrin type-B receptor 4 (EPHB4) inhibits MDA-MB 435 breast cancer cell invasion through an ABL-CrkII signaling pathway [10] and ABL activation can inhibit TGFβ oncogenic signaling in the murine breast cell line 4T1 [11]. The gene discussed is ABL1; the disease is breast carcinoma.